Scarica l'app Stockscreener
7.28
3.45%
-0.26
Pre-mercato:
7.18
-0.10
-1.37%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.54
Aprire:
$7.48
Volume 24 ore:
2.48M
Relative Volume:
1.34
Capitalizzazione di mercato:
$749.13M
Reddito:
-
Utile/perdita netta:
$-51.99M
Rapporto P/E:
-6.5262
EPS:
-1.1155
Flusso di cassa netto:
$-45.31M
1 W Prestazione:
-12.39%
1M Prestazione:
+9.15%
6M Prestazione:
+70.09%
1 anno Prestazione:
+121.95%
Intervallo 1D:
$7.21
$7.56
Intervallo di 1 settimana:
$7.21
$8.56
Portata 52W:
$2.62
$8.64
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
7.28 | 749.13M | 0 | -51.99M | -45.31M | -1.1155 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 130.42B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 81.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 61.56B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.54B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 43.59B | 742.00K | -1.37B | -1.07B | -7.0731 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-21 | Iniziato | Canaccord Genuity | Buy |
| 2025-11-25 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-08-21 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2024-09-27 | Iniziato | Raymond James | Strong Buy |
| 2023-05-10 | Reiterato | Maxim Group | Buy |
| 2021-06-23 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
Bank of New York Mellon Corp Buys Shares of 218,126 Achieve Life Sciences, Inc. $ACHV - MarketBeat
Wellington Management Group LLP Buys New Stake in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Frazier Life Sciences Management L.P. Buys New Stake in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Achieve Life Sciences Stock Price Forecast. Should You Buy ACHV? - StockInvest.us
Achieve Life Sciences Grants Equity Awards to 7 New Employees Under 2024 Inducement Plan - Quiver Quantitative
Seven new employees receive stock awards from Achieve Life Sciences - Stock Titan
Achieve Life Sciences (NASDAQ:ACHV) Sets New 1-Year HighHere's What Happened - MarketBeat
BlackRock Inc. Invests $34.43 Million in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Up 5.2%Time to Buy? - MarketBeat
Alyeska Investment Group L.P. Acquires Shares of 1,925,722 Achieve Life Sciences, Inc. $ACHV - MarketBeat
Jupiter Topco LLC Acquires Shares of 2,751,032 Achieve Life Sciences, Inc. $ACHV - MarketBeat
Achieve Life Sciences Inc. (ACHV) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Spruce Street Capital LP Purchases Shares of 736,637 Achieve Life Sciences, Inc. $ACHV - MarketBeat
Achieve Life Sciences Inc. (ACHV) Key Financial Ratios – Valuation, Profitability & More - Value Research
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
This Insider Has Just Sold Shares In Achieve Life Sciences - simplywall.st
Insider Selling: Achieve Life Sciences (NASDAQ:ACHV) Director Sells $175,114.74 in Stock - MarketBeat
Achieve Life (NASDAQ: ACHV) director keeps 208,249 shares after sale - Stock Titan
Achieve Life (NASDAQ: ACHV) director to sell 20,626 shares - Stock Titan
Achieve Life Sciences (NASDAQ:ACHV) Sets New 12-Month HighShould You Buy? - MarketBeat
Achieve Life Sciences (ACHV) draws new passive holder near 10% - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Achieve Life Sciences Inc (ACHV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Achieve Life Sciences (NASDAQ:ACHV) Stock Rating Lowered by Wall Street Zen - MarketBeat
Achieve Life SciencesEnters ATM Sale Agreement With Jefferies For Up To $150 Million In Common Stock - TradingView
Achieve Life Sciences (ACHV) launches $150M at-the-market stock program - Stock Titan
Achieve Life Sciences, Inc. (NASDAQ:ACHV): When Will It Breakeven? - Moomoo
Achieve Life Sciences, Inc. (NASDAQ:ACHV): Is Breakeven Near? - simplywall.st
(08/14/26) ACHV: A Speculative Trade in the Biotech Sector - moneyshow.com
ACHV Q1 2026 Earnings: Smaller-Than-Expected Loss Lifts Shares 8.37%Long-Term Guidance - vinanet.vn
Janus Henderson Group (ACHV) reports 5,502,064 Achieve Life shares under management - Stock Titan
This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Achieve Life Sciences' Cytisinicline to Unlock $760 Million Market Opportunity in Smoking Cessation, Morgan Stanley Says - marketscreener.com
Achieve Life Sciences, Inc. Stock 12‑Month Price Target Cut to $13.83, Implies 107% Upside - TradingView
Achieve Life Sciences (NASDAQ:ACHV) Hits New 12-Month HighHere's Why - MarketBeat
Achieve stock gains Overweight at Morgan Stanley (ACHV:NASDAQ) - Seeking Alpha
HC Wainwright Has Optimistic Outlook of ACHV Q3 Earnings - MarketBeat
ACHV Initiates Coverage On by Morgan Stanley -- Rating Set to Ov - GuruFocus
Morgan Stanley Initiates Achieve Life Sciences at Overweight, With $13 Price Target - marketscreener.com
Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit. - webull.com
Morgan Stanley initiates Achieve Life Sciences stock at overweight By Investing.com - Investing.com Nigeria
Morgan Stanley initiates Achieve Life Sciences stock at overweight - Investing.com
H.C. Wainwright reiterates Achieve Life Sciences stock rating at buy By Investing.com - Investing.com Canada
Research Analysts Set Expectations for ACHV FY2028 Earnings - MarketBeat
Achieve Life Sciences Submits Q2 2026 Form 10-Q Highlighting NDA Resubmission and Financial Risks - Kalkine Media
Achieve Life Sciences Releases Q2 2026 Financial Results - AlphaStreet
ACHIEVE LIFE SCIENCES, INC. 6M 2026: Net loss $(84.9)M, EPS $(1.15) — 10-Q Summary - TradingView
Achieve Life Sciences (ACHV) swings to larger $84.9M loss on warrant costs - stocktitan.net
Achieve Life Sciences (NASDAQ: ACHV) posts larger Q2 2026 loss but secures $354M financing - Stock Titan
FDA declines to approve Achieve smoking cessation drug; Q4 resubmission planned - scanx.trade
Achieve Life Sciences Q2 Results: EPS misses estimate, losses widen - scanx.trade
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):